Pharma, patient advocates clash over Inflation Reduction Act
Pharmaceutical Technology
MAY 17, 2023
Merith Basey, the executive director of the advocacy group Patients for Affordable Drugs, said that CMS’s lack of negotiating power is a key reason that US patients pay up to four times as much for drugs as patients in other countries.
Let's personalize your content